NRC Stock Analysis: Buy, Sell, or Hold?
NRC - National Research Corporation Common Stock (Delaware)
$21.90
1.56 (7.67%)
β²
5d:
+5.26%
30d:
+16.68%
90d:
+67.18%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 02, 2026
0d
Get Alerted When NRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: NRC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
π HOLD: NRC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NRC is currently trading at $21.90, which is considered extended relative to its 30-day fair value range of $18.96 to $21.49.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.53, while resistance sits at $22.79. The stock is showing strong short-term momentum, up 7.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRC is in a strong uptrend. Immediate support is located at $19.53, while resistance sits at $22.79. The stock is showing strong short-term momentum, up 7.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$18.96 -
$21.49
Company Quality Score
54/100
(HOLD)
Options IV Signal
46th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
55.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 46th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.7%)
Fair Price Analysis
30-Day Fair Range
$18.96 -
$21.49
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
Β±$2.09
(9.5%)
Support & Resistance Levels
Support Level
$19.53
Resistance Level
$22.79
Current Trend
Strong Uptrend
Fundamental Context
Revenue Growth (YoY)
-3.4%
Earnings Growth (YoY)
-24.9%
Profit Margin
11.8%
Last updated: February 03, 2026 4:54 AM ET
Data refreshes hourly during market hours. Next update: 5:54 AM
Data refreshes hourly during market hours. Next update: 5:54 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 52 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 55 HOLD |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 64 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 64 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 49 HOLD |